[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367241-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367241-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unveiling-ssr4-a-promising-biomarker-in-esophageal-squamous-cell-carcinoma-research-article","Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma - Research article","","Esophageal squamous cell carcinoma (ESCC) is a frequent malignancy with poor prognosis, and altered glucose metabolism is implicated in its progression. Using bulk RNA-seq from 110 patients with complete follow-up, the study evaluates differential expression and prognostic significance of SSR4 and validates findings by RT-qPCR and IHC. Single-cell analyses identify the cell subset with the highest SSR4 expression and connect SSR4 with immune infiltration, especially plasma cells, and tumor microenvironment interactions via the MIF/CD74/CXCR4 axis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unveiling-ssr4-a-promising-biomarker-in-esophageal-squamous-cell-carcinoma-research-article/367241/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unveiling-ssr4-a-promising-biomarker-in-esophageal-squamous-cell-carcinoma-research-article/367241.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of this study on SSR4 in ESCC?","Question",{"text":63,"@type":64},"To clarify the relationship between SSR4 expression and the clinical characteristics of esophageal squamous cell carcinoma, and to explore its underlying mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was SSR4 expression measured and validated?",{"text":68,"@type":64},"SSR4 differential expression and prognostic value were assessed using bulk RNA-seq data, and SSR4 upregulation in ESCC was validated by RT-qPCR and IHC staining.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinical and immunological associations were found for SSR4?",{"text":72,"@type":64},"SSR4 expression correlated with N stage, lymph node metastasis, and AJCC TNM stage; low SSR4 expression was linked to a more favorable prognosis. The highest SSR4 expression was observed in tumor plasma cells, and SSR4 was associated with plasma-cell infiltration and TME interactions through the MIF/CD74/CXCR4 axis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367241,1790196196,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 24 February 2025 DOI 10.3389/fimmu.2025.1544154  \nOPEN ACCESS  \nEDITED BY  \nMonde Ntwasa,  \nUniversity of South Africa, South Africa  \nREVIEWED BY  \nSakshi M.,  \nEmory University, United States Yan-Mei Jiao,  \nFifth Medical Center of the PLA General Hospital, China  \nZhen Feng,  \nWenzhou Medical University, China  \n*CORRESPONDENCE  \nShunzhe Song  \n [1045322650@qq.com](1045322650@qq.com)[ ](1045322650@qq.com)Aixia Gong  \n [doctorgax@sina.com](doctorgax@sina.com)  \n†These authors have contributed equally to this work  \nRECEIVED 12 December 2024  \nACCEPTED 10 February 2025  \nPUBLISHED 24 February 2025  \nCITATION  \nZhang J, Jia F, Li C, Song S and Gong A (2025) Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma. Front. Immunol. 16:1544154 .  \ndoi: 10.3389/fimmu.2025.1544154  \nCOPYRIGHT  \n© 2025 Zhang, Jia, Li, Song and Gong. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nUnveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma  \nJiaqi Zhang 1†, Fang Jia 1†, Chuqiao Li 2, Shunzhe Song 1* and Aixia Gong 1*  \n1 Department of Digestive Endoscopy, The First Afﬁliated Hospital of Dalian Medical University, Dalian, Liaoning, China, 2 Department of Gastroenterology, The First Afﬁliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China  \nBackground: Esophageal squamous cell carcinoma (ESCC) represents a frequent cancer with a poor prognosis. Altered glucose metabolism contributes factor to ESCC progression. In our previous study, signal sequence receptor subunit delta (SSR4) was included in an ESCC prognostic model; however, the mechanisms underlying SSR4 implication in ESCC remain ambiguous. Accordingly, we aim to determine the interconnection between SSR4 expression and clinical characteristics of ESCC.  \nMethods: This differential expression and prognostic signiﬁcance of SSR4 was performed using bulk RNA-seq data and 110 patients with complete follow-up information. The ESCC cell subsets with the highest gene expression levels were identiﬁed with single-cell data. Gene function and enrichment, immune inﬁltration, cell communication, and molecular docking analyses were performed.  \nResults: Unlike adjacent non-cancerous tissues, SSR4 was overexpressed in ESCC tissues, validated by both reverse transcription-qPCR and IHC staining. SSR4 expression was related to the N stage, lymph node metastasis, and AJCC TNM classiﬁcation stage. Patients exhibiting low SSR4 expression had a more favorable prognosis. The highest SSR4 expression was recognized in tumor plasma cells. Continued exploration of immune inﬁltration highlighted a close association between SSR4 gene expression and the inﬁltration of immune cells such as plasma cells. On dividing cells into SSR4-positive and-negative groups, CellChat analysis indicated that SSR4 may regulate the interactions that existed between ESCC tumor plasma cells and the tumor microenvironment (TME) by modulating the MIF/CD74/CXCR4 axis.  \nConclusion: The SSR4 gene may have signiﬁcant relevance with clinical pathological factors, and play a critical role in the regulation of tumor microenvironment of ESCC patients. Overall, SSR4 may be a promising ESCC biomarker with prospective applicability in clinical diagnosis as well as the development of targeted treatment approaches in patients of ESCC.  \nKEYWORDS  \nesophageal squamous cell carcinoma, SSR4, biomarker, single-cell transcriptomics, immune cells  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nAmong all aggressive malignancies, esophagea","cbCaieANuJnNKqZD","https://ap.wps.com/l/cbCaieANuJnNKqZD","pdf",14257184,15,"English","# Introduction\n# Background and rationale\n# Methods\n## Data sources and analyses\n# Results\n## SSR4 expression and clinical associations\n## Single-cell findings and immune infiltration\n## Cell communication and TME axis\n# Conclusion","[{\"question\":\"What was the main goal of this study on SSR4 in ESCC?\",\"answer\":\"To clarify the relationship between SSR4 expression and the clinical characteristics of esophageal squamous cell carcinoma, and to explore its underlying mechanisms.\"},{\"question\":\"How was SSR4 expression measured and validated?\",\"answer\":\"SSR4 differential expression and prognostic value were assessed using bulk RNA-seq data, and SSR4 upregulation in ESCC was validated by RT-qPCR and IHC staining.\"},{\"question\":\"What clinical and immunological associations were found for SSR4?\",\"answer\":\"SSR4 expression correlated with N stage, lymph node metastasis, and AJCC TNM stage; low SSR4 expression was linked to a more favorable prognosis. The highest SSR4 expression was observed in tumor plasma cells, and SSR4 was associated with plasma-cell infiltration and TME interactions through the MIF/CD74/CXCR4 axis.\"}]","Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma - Research article | PDF",1790169853,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cd6f2011bfbfef5694e41de89a986b9.webp",983,1389,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98d079edfa52758cc6433485ec0ca5e0.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d895f9ba71ac4e4691d61ce0e608b76f.webp",981,1386,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61d9bb12cfa52d3b4e8514a331347c69.webp",980,1385]